Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

Cedars Sinai Medical Center, Los Angeles

Stanford University, Palo Alto

Huntington Memorial Hospital Liver Center, Pasadena

Medical Associates Research Group, Inc., San Diego

University of Colorado, Aurora

Borland-Groover Clinic, Jacksonville

University of Miami, Miami

Orlando Immunology center, Orlando

South Florida Center of Gastroenterology, P.A., Wellington

Center for Hep C/Atlanta Medical Center, Atlanta

Gastrointestinal Specialists of Georgia, PC, Marietta

University of Chicago, Chicago

Indiana University School of Medicine, Indianapolis

Indianapolis Gastroenterology & Hepatology, Inc., Indianapolis

Beth Isreal Deconess Medical Center, Boston

Massachusetts General Hospital, Boston

Henry Ford Hospital and Health System, Detroit

ID Care, Hillsborough

Southwest Care Center, Santa Fe

North Shore/Long Island Jewish PRIME, Manhasset

Mount Sinai Beth Israel, New York

Cumberland Research Associates, LLC, Fayetteville

Digestive Health Specialists, PA, Winston-Salem

University of Pennsylvania Health Systems, Philadelphia

UPMC Center for Liver Diseases, Pittsburgh

Medical University of South Carolina, Charleston

Gastro One, Germantown

Nashville Gastrointestinal Specialists Inc., Nashville

Texas Liver Institute, San Antonio

Liver Institute of Virginia, Richmond

Swedish Medical, Seattle

Christchurch Clinical Studies Trust, Christchurch

Auckland Clinical Studies, Grafton

Fundacion de Investigacion de Diego, San Juan